Overview

Detailed Summary

Jeena Sikho Lifecare Limited is an integrated Ayurvedic healthcare company operating a dual model of hospitals/clinics (services) and an OTC/personal care products business, running a hub‑and‑spoke network across 23 states with 58 hospitals, 59 clinics/day‑care centres and several thousand beds operational and in development.
Q3 FY26 performance shows sharp operational momentum: Revenue at ₹221.7 crore (▲92% YoY, ▲17% QoQ), EBITDA ₹100.8 crore with a 45% margin and PAT ₹66.7 crore at a 30% margin, highlighting unusually high profitability for a healthcare chain driven by product margins and operating leverage in services.
The company’s business model is capital‑light: management reports per‑bed set‑up costs of ₹3–4 lakh, 35/117 facilities run by franchisees, and a stated 71% 3‑year ROCE, enabling fast scalability while preserving a relatively robust balance sheet and low reported borrowings historically.
Products and services are roughly parity contributors to recent revenue (about 49% services, 51% products for 9MFY26) with product gross margins near ~85%, providing strong cash generation that funds service expansion and supports rapid OTC rollouts via new distribution tie‑ups like Entero.
Strategic growth levers include an international push (UAE, Kazakhstan, Nepal), a diagnostics partnership with Chandan, a planned Jeena Sikho Health Card for customer loyalty, and a target long‑term ambition of 7,000–10,000 beds alongside an accelerated OTC product roadmap.

Sector: Pharmaceuticals
Industry: Trading - Medium / Small
Market Cap: 7,577 Cr
Volatility: Moderate Risk
P/E Ratio: 24.8
Industry P/E: 37.2
PEG Ratio: 2.4
P/B Ratio: 21.4
52W High: 850.00
52W Low: 516.50

Sales CAGR

1Y: 39.71%
3Y: 47.41%
5Y: 37.80%
10Y: —

Profit CAGR

1Y: 199.55%
3Y: 100.41%
5Y: 73.77%
10Y: —

ROE

TTM: 42.02%
3Y: 32.77%
5Y: 33.03%
10Y: —

ROCE

TTM: 46.06%
3Y: 44.01%
5Y: 44.66%
10Y: —

Technicals

Oscillators

BearishNeutralBullish

Bullish

Bearish

Neutral

Bullish

Overall

BearishNeutralBullish

Bearish

Neutral

Bullish

Moving Averages

BearishNeutralBullish

Bearish

Neutral

Bullish

Overall

BearishNeutralBullish

Bearish

Neutral

Bullish

Forecasts

Peers

Symbol	Price	Market Cap	P/E	P/B	Div Yield (%)	ROE (%)	ROCE (%)	ROA (%)
CELLO	421.50	9,218 Cr	29.91	4.02	0.36	14.53	21.06	12.03
MMTC	55.89	8,406 Cr	31.76	4.37	0.00	3.66	6.64	6.97
JSLL	614.95	7,577 Cr	24.76	21.43	0.18	42.02	46.06	36.87
LLOYDSENT	46.23	6,899 Cr	18.11	2.08	0.18	8.52	11.92	6.12
REDTAPE	123.00	6,772 Cr	32.03	7.90	1.84	21.08	17.42	9.26
ETHOSLTD	2330.10	6,233 Cr	65.00	4.35	0.00	6.63	8.64	4.49
AVL	477.00	6,199 Cr	55.68	9.70	0.23	16.92	17.45	9.27

Financial Statements

AI Powered Summary

Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.

Ask AI

Consolidated Quarterly Results (in ₹ Crores)

View Standalone

Total Figures

QoQ Changes

Total Figures

	Dec 2024	Sep 2025	Dec 2025
Sales	116	190	222
Expenses	86	98	121
Operating Profit	30	92	101
OPM %	25.59	48.48	45.43
Other Income	0.39	1.44	2.57
Interest	3.79	4.35	3.10
Depreciation	8.47	10	11
Profit Before Tax	18	79	89
Tax %	25.54	25.38	25.11
Net Profit	13	59	67
EPS in Rs	—	4.72	5.35

Consolidated Profit Loss (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2022	Mar 2023
Sales	147	205
Expenses	129	159
Operating Profit	18	46
OPM %	12.32	22.27
Other Income	1.49	2.60
Interest	1.14	0.70
Depreciation	3.31	3.20
Profit Before Tax	15	44
Tax %	25.83	24.32
Net Profit	11	34
EPS in Rs	—	—
Dividend Payout %	0.00	8.05

Consolidated Balance Sheet (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2022	Mar 2023
Equity Capital	10	14
Reserves	26	112
Borrowings	7.43	0.81
Other Liabilities	18	24
Total Liabilities	62	151
Fixed Assets	29	60
CWIP	5.04	1.13
Investments	0.00	4.55
Other Assets	28	86
Total Assets	62	151

Consolidated Cash Flows (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2022	Mar 2023
Cash from Operating Activity	16	15
Cash from Investing Activity	-18	-33
Cash from Financing Activity	-4.51	48
Net Cash Flow	-6.65	29

Shareholdings

Shareholding History

Quarterly

Yearly

Quarterly

	Apr 2022	Sep 2022	Mar 2023	Sep 2023	Nov 2023	Mar 2024	Sep 2024	Mar 2025	Jun 2025	Aug 2025	Sep 2025	Dec 2025
Promoters	65.89%	65.89%	66.20%	67.91%	67.91%	67.91%	65.84%	63.53%	63.53%	63.53%	63.61%	63.62%
FIIs	0.00%	0.00%	0.00%	2.00%	1.79%	0.26%	4.05%	5.95%	5.91%	5.96%	6.59%	6.31%
DIIs	0.00%	0.00%	0.00%	0.04%	0.00%	0.00%	0.07%	0.17%	0.18%	0.18%	0.15%	0.11%
Public	34.11%	34.11%	33.80%	30.05%	30.30%	31.83%	30.04%	30.34%	30.38%	30.32%	29.65%	29.96%
Total Shareholders	1,951	834	663	814	1,107	2,721	3,423	5,967	6,603	7,434	16,362	22,181

Market Transactions

Unlock Premium Features

Analyst Target, Price, EPS and Revenue Projections

Upgrade

Projection

Documents

Presentations

Concalls

Reports

Presentations

Investor Presentation

Q3 FY26

Investor Presentation

Q2 FY26

Investor Presentation

Q1 FY26

Available on Pro Plan